Dubai is reinventing healthcare — from AI-powered diagnostics to pharmaceutical manufacturing — and India’s tech, wellness, ...

We think CR Pharma has a weaker financial position compared with the top three medical distributors. Similar to other pharmaceutical distributors, accounts receivable make up a large portion of its ...

Discussions also focused on Egypt’s pharmaceutical and vaccine manufacturing capabilities, as well as reactivating the cooperation protocol between the health ministries of both countries ...

Eli Lilly and Company, AbbVie, Merck & Co., Inc., Pfizer, D-Wave Quantum, Johnson & Johnson, and Amgen are the seven ...

Sri Lanka's National Medicine Regulatory Authority will seek court approval for a price formula for a large number of drugs, ...

Digging deeper into the BIO survey results, 94% of companies polled said they expect tariffs on the European Union (EU) to ...

Costs for essential medications such as those used to treat cancer, diabetes, heart conditions, and Antibiotics are projected to increase. The prices of controlled category medicines are anticipated ...

Health care is one of the biggest industries in the U.S. economy. In 2023, it accounted for 17% of the nation’s total ...

Compounding pharmacies have emerged as a crucial player in the evolving landscape of personalized medicine, offering ...

Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine targeting a chronic blood disorder.

Two UIC professors list their questions for the man set to lead "the crown jewel” of American biomedical science.

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.